Jump to main content
Jump to site search

Issue 43, 2007
Previous Article Next Article

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Author affiliations

Abstract

The success of the clinical uses of cisplatin, cis-[PtII(NH3)2Cl2], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(III), platinum(II), ruthenium(II, III, IV), iron(II) and vanadium(IV) complexes for anti-cancer and anti-HIV treatments.

Graphical abstract: Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 03 Apr 2007, accepted on 04 Jun 2007 and first published on 18 Sep 2007


Article type: Perspective
DOI: 10.1039/B705079H
Citation: Dalton Trans., 2007, 4884-4892
  •   Request permissions

    Some uses of transition metal complexes as anti-cancer and anti-HIV agents

    R. Wai-Yin Sun, D. Ma, E. L. Wong and C. Che, Dalton Trans., 2007, 4884
    DOI: 10.1039/B705079H

Search articles by author